OLX-202

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameOLX-202

Drug Alias Nameself-delivering RNAi agent for asthma(OliX Pharmaceuticals)Cell penetrating asymmetric siRNA (OliX Pharmaceuticals)OLX-202

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOlix Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOlix Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsAsthma

Other Information

ATC CodeN/A